We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
-27.97%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$436M
AUM Growth
-$177M
Cap. Flow
+$6.16M
Cap. Flow %
1.41%
Top 10 Hldgs %
100%
Holding
8
New
4
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
PBYI icon
Puma Biotechnology
PBYI
+$7.43M
2
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$3.9M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$1.16M
4
EQ icon
Equillium
EQ
+$658K
5
PRTA icon
Prothena Corp
PRTA
+$566K

Top Sells

Rank Stock Value
1
LJPC
La Jolla Pharmaceutical Company
LJPC
+$3.91M
2
HRTX icon
Heron Therapeutics
HRTX
+$3.64M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ODT
1
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$198M 45.38%
14,047,250
+250,503
+2% +$3.9M
HRTX icon
2
Heron Therapeutics
HRTX
$86.3M
$151M 34.63%
5,818,541
-132,285
-2% -$3.64M
RCKT icon
3
Rocket Pharmaceuticals
RCKT
$348M
$43.9M 10.08%
2,965,485
– –
LJPC
4
DELISTED
La Jolla Pharmaceutical Company
LJPC
$36.6M 8.39%
3,878,893
-260,000
-6% -$3.91M
PBYI icon
5
Puma Biotechnology
PBYI
$406M
$5.04M 1.16%
+247,400
New +$7.43M
ISEE
6
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$720K 0.17%
+600,000
New +$1.16M
PRTA icon
7
Prothena Corp
PRTA
$458M
$490K 0.11%
+47,610
New +$566K
EQ icon
8
Equillium
EQ
$157M
$386K 0.09%
+47,343
New +$658K

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $1.98B AUM 1.62% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return

Tang Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Tang Capital Management held 8 positions worth $436M, down 29% from $612M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tang Capital Management's Q4 2018 filing shows 4 new, 1 increased and 2 reduced positions. Its largest new stake was Puma Biotechnology: 247,400 shares worth $5.04M. The largest sale was La Jolla Pharmaceutical Company, an estimated $3.91M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tang Capital Management's largest Q4 2018 buy was Puma Biotechnology: 247,400 shares worth $5.04M.
  • Tang Capital Management added most to Odonate Therapeutics, Inc. Common Stock in Q4 2018, an estimated $3.9M increase.
  • Tang Capital Management's biggest Q4 2018 reduction was La Jolla Pharmaceutical Company, cutting an estimated $3.91M.
  • Tang Capital Management's ten largest holdings make up 100% of its $436M portfolio in Q4 2018.
  • Tang Capital Management opened 4 new positions and closed 0 in Q4 2018.
  • Tang Capital Management's portfolio value fell 29% quarter-over-quarter to $436M.

Based on Tang Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.